Futura Medical PLC (LSE:FUM) - Share price - Overview

Stock Report

Futura Medical PLC FUM

Last Price
GBX53.00

Day Change
0.00|0.00%

As of 27/02/2017
15:50:40 GMT | GBX
Minimum 15 Minutes Delay.

Last Close53.00p
Day Range52.25 - 53.65
Mkt Cap63.93Mil
52-Wk Range14.31 - 95.60
Yield %0.00
ISINGB0033278473
Volume42,948
P/E-10.33
P/S1,827.59
P/CF-9.88

Share Price

Total Returns 24/02/2017

 Chg (%)  
More ...
Futura Medical PLC-4.93 
FTSE 100 TR GBP2.08
 
Financials
201320142015
More ...
Income Statement
Turnover0.370.040.03
Operating Profit-2.53-3.53-6.12
Net Profit-2.21-3.00-5.08
Reported EPS-2.85-3.35-5.13
Balance Sheet
Current Assets1.4610.325.50
Non Current Assets0.010.010.02
Total Assets1.4710.335.52
Current Liabilities0.480.610.73
Total Liabilities0.480.610.73
Total Equity0.999.724.79
Cash Flow
Operating Cash Flow-2.28-3.38-5.84
Net Change in Cash-1.838.50-5.30
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-3.94-3.22--16.44---
2017-6.31-4.39--12.06---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
17/01/2017Transfer OutJames Barder0.0050,0000.00
12/01/2017Sale of Option SharesJames Barder55.17210,000115,861.00
12/01/2017Exercise of OptionJames Barder40.50250,000101,250.00
12/01/2017Sale of Option SharesDerek Martin55.17100,00055,172.00

Company Profile

Futura Medical PLC is engaged in the research & development of medical devices & pharmaceutical drugs and their commercial exploitation with the focus being on OTC products for sexual healthcare & pain relief management.

Sector

Drug Manufacturers - Major

Market Position

1024 of 1853 Companies

Index

FTSE AIM All Share

Outlook

(13/09/2016) no outlook statement

Next Event 15/03/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)-12.0614.3416.13
Div Yld (E)0.003.764.10
PEG (E)0.00-0.431.08
ROCE-127.00202.62104.73
Op Mrgn-21,089.66-9.81-16.30
EPS Grwth0.0043.0235.18
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. John Clarke
Chief ExecutiveJames Barder
Finance Director & Company SecretaryDerek Martin
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.